Cell Medica: Lead Cancer Immunotherapy Candidate Receives FDA Fast Track Designation – Yahoo Finance
|
Cell Medica: Lead Cancer Immunotherapy Candidate Receives FDA Fast Track Designation
Yahoo Finance Cell Medica, a leader in developing cellular immunotherapy for the treatment of cancer, today announced the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to its lead oncology product CMD-003 for patients with … New Immunotherapy Candidate receives FDA Fast Track Designation |
